EP2970255
Efnasambönd og lyfjafræðilegar samsetningar þar af til meðferðar á bólgusjúkdómum
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
7.3.2014EP published:
2.8.2017EP application number:
14708291.1
EP translation filed:
11.8.2017Grant published:
15.9.2017EPO information:
European Patent Register
Max expiry date:
6.3.2034Expiry date:
6.3.2024
Title:
COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS
Timeline
Today
7.3.2014EP application
2.8.2017EP Publication
11.8.2017Translation submitted
15.9.2017Registration published
6.3.2024Expires
Owner
Name:
Galapagos NVAddress:
Generaal De Wittelaan L11/A3, 2800, Mechelen, BE
Inventor
Name:
DESROY, NicolasAddress:
Romainville, FR
Name:
HECKMANN, BertrandAddress:
Romainville, FR
Name:
BRYS, Reginald Christophe XavierAddress:
Mechelen, BE
Name:
JONCOUR, AgnèsAddress:
Romainville, FR
Name:
PEIXOTO, ChristopheAddress:
Romainville, FR
Name:
BOCK, XavierAddress:
Romainville, FR
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201361781174 PDate:
14.3.2013Country:
US
Classification
Categories:
C07D 471/04, A61K 31/437, A61P 35/00, A61P 37/00, A61P 29/00, A61P 25/28, A61P 11/00, A61P 9/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 8.2.2018
Expires: 6.3.2019
Payer: Árnason Faktor
Number: 6
Paid: 7.2.2019
Expires: 6.3.2020
Payer: Árnason Faktor
Number: 7
Paid: 18.2.2020
Expires: 6.3.2021
Payer: Árnason Faktor ehf.
Number: 8
Paid: 8.2.2021
Expires: 6.3.2022
Payer: Árnason Faktor ehf.
Number: 9
Paid: 8.2.2022
Expires: 6.3.2023
Payer: Árnason Faktor ehf.
Number: 10
Paid: 8.2.2023
Expires: 6.3.2024
Payer: Árnason Faktor ehf.